Stonepine Capital Management, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$123.9B
Holdings
52
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (52 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ADMAADMA BIOLOGICS INC | 1,241,032 | $21.3B | 17.18% | |
| 2 | EOLSEVOLUS INC | 1,264,651 | $14.0B | 11.27% | |
| 3 | TELATELA BIO INC | 2,353,099 | $7.1B | 5.74% | |
| 4 | GLPGGALAPAGOS NV-SPON ADR | 200,000 | $5.5B | 4.44% | |
| 5 | ZVRAZEVRA THERAPEUTICS INC | 597,700 | $5.0B | 4.02% | |
| 6 | VSTMVERASTEM INC | 870,000 | $4.5B | 3.63% | |
| 7 | ACADACADIA PHARMACEUTICALS INC | 220,000 | $4.0B | 3.26% | |
| 8 | 0OPOPTINOSE INC | 588,657 | $3.9B | 3.17% | |
| 9 | ANIKANIKA THERAPEUTICS INC | 238,222 | $3.9B | 3.17% | |
| 10 | —INDIVIOR PLC | 305,000 | $3.8B | 3.06% | |
| 11 | ESTAESTABLISHMENT LABS HOLDINGS | 80,002 | $3.7B | 2.98% | |
| 12 | IKTINHIBIKASE THERAPEUTICS INC | 1,132,388 | $3.7B | 2.97% | |
| 13 | URGNUROGEN PHARMA LTD | 324,324 | $3.5B | 2.79% | |
| 14 | XOMAXOMA CORP | 125,700 | $3.3B | 2.67% | |
| 15 | DAWNDAY ONE BIOPHARMACEUTICALS I | 235,000 | $3.0B | 2.40% | |
| 16 | IRWDIRONWOOD PHARMACEUTICALS INC | 648,785 | $2.9B | 2.32% | |
| 17 | SCPHSCPHARMACEUTICALS INC | 683,530 | $2.4B | 1.95% | |
| 18 | SRZNSURROZEN INC | 137,200 | $2.0B | 1.59% | |
| 19 | INOINOVIO PHARMACEUTICALS INC | 1,050,000 | $1.9B | 1.55% | |
| 20 | ENTAENANTA PHARMACEUTICALS INC | 331,900 | $1.9B | 1.54% | |
| 21 | MYOMYOMO INC | 274,426 | $1.8B | 1.43% | |
| 22 | CALCCALCIMEDICA INC | 468,793 | $1.7B | 1.34% | |
| 23 | ACRSACLARIS THERAPEUTICS INC | 663,405 | $1.6B | 1.33% | |
| 24 | PRNPROFOUND MEDICAL CORP | 200,000 | $1.5B | 1.21% | |
| 25 | JAZZJAZZ PHARMACEUTICALS PLC US LISTED | 10,000 | $1.2B | 0.99% | |
| 26 | VIRVIR BIOTECHNOLOGY INC | 164,106 | $1.2B | 0.97% | |
| 27 | MISTMILESTONE PHARMACEUTICALS IN | 500,000 | $1.2B | 0.95% | |
| 28 | BSFAANI PHARMACEUTICALS INC | 20,400 | $1.1B | 0.91% | |
| 29 | HRTXHERON THERAPEUTICS INC | 700,000 | $1.1B | 0.86% | |
| 30 | XGNEXAGEN INC | 251,049 | $1.0B | 0.83% | |
| 31 | TSVT*2SEVENTY BIO INC | 300,000 | $882.0M | 0.71% | |
| 32 | 5E7ITEOS THERAPEUTICS INC | 110,000 | $844.8M | 0.68% | |
| 33 | PMVPPMV PHARMACEUTICALS INC | 535,805 | $809.1M | 0.65% | |
| 34 | KZRKEZAR LIFE SCIENCES INC | 110,000 | $739.2M | 0.60% | |
| 35 | AYTUAYTU BIOPHARMA INC | 407,549 | $692.8M | 0.56% | |
| 36 | TORCEURADICET BIO INC | 700,000 | $673.4M | 0.54% | |
| 37 | KPRXKIORA PHARMACEUTICALS INC | 200,970 | $663.2M | 0.54% | |
| 38 | XERSXERIS BIOPHARMA HOLDINGS INC | 182,317 | $618.1M | 0.50% | |
| 39 | AQSTAQUESTIVE THERAPEUTICS INC | 160,000 | $569.6M | 0.46% | |
| 40 | APREAPREA THERAPEUTICS INC | 149,221 | $490.9M | 0.40% | |
| 41 | SLRNACELYRIN INC | 132,870 | $417.2M | 0.34% | |
| 42 | CHRSCOHERUS BIOSCIENCES INC | 250,000 | $345.0M | 0.28% | |
| 43 | PYPDPOLYPID LTD | 103,668 | $315.2M | 0.25% | |
| 44 | HLVXHILLEVAX INC | 132,347 | $274.0M | 0.22% | |
| 45 | ANTXAN2 THERAPEUTICS INC | 196,732 | $271.5M | 0.22% | |
| 46 | VNDAVANDA PHARMACEUTICALS INC | 25,000 | $119.8M | 0.10% | |
| 47 | —ELEVATION ONCOLOGY INC | 200,000 | $112.5M | 0.09% | |
| 48 | ABVXABIVAX SA | 15,000 | $109.8M | 0.09% | |
| 49 | —ALIMERA SCIENCES INC CVR | 2,408,469 | $107.1M | 0.09% | |
| 50 | ALLRALLARITY THERAPEUTICS INC | 67,289 | $78.7M | 0.06% | |
| 51 | RVNCEURREVANCE THERAPEUTICS INC | 23,264 | $70.7M | 0.06% | |
| 52 | AMRNAMARIN CORPORATION PLC -ADR | 114,257 | $55.4M | 0.04% |